Shanghai Fosun Pharma's Corona Testing Kit capable of 96 samples in two hours gets American FDA Emergency Use Authorization

Fosun Pharma Receives FDA Emergency Use Authorization (EUA) For Its COVID-19 RT-PCR Detection Kit

SHANGHAI, April 19, 2020 According to the website of the U.S. Food and Drug Administration ("FDA"), Shanghai Fosun Pharmaceutical (Group) Co., Ltd ("Fosun Pharma"; Stock Code: 600196.SH, 02196.HK) has received emergency use authorization (EUA) from FDA for its COVID-19 RT-PCR detection kit.

Infant Formula Probiotic Bifidobacteriumlongum BB536 by Morinaga Milk Gets FDA GRAS

Morinaga Milk Obtains FDA GRAS Approval for Its Probiotic Bifidobacteriumlongum BB536 in Infant Formula

Wednesday, April 8, 2020 Tokyo, Japan: Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Morinaga Bifidobacterium longum BB536 has received FDA GRAS (Generally Recognized as Safe) approval relating to its use in term infant formula.